PubRank

Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 29084829)

Published in Gut on October 30, 2017

Authors

Hamza Chettouh1, Oliver Mowforth1, Núria Galeano-Dalmau1, Navya Bezawada1, Caryn Ross-Innes1, Shona MacRae1, Irene Debiram-Beecham1, Maria O'Donovan2, Rebecca C Fitzgerald1

Author Affiliations

1: MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
2: Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.

Articles by these authors ⇆

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet (2014) 3.75

Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nat Genet (2015) 1.89

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol (2016) 0.75